Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Southern Cross Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (263)
Cancellation by sponsor (205)
Prescription medicine registration (22)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2026 (6)
2025 (5)
2024 (16)
2023 (30)
2022 (102)
2021 (29)
2020 (50)
2019 (59)
2018 (35)
2017 (50)
2016 (22)
2015 (17)
2014 (9)
2013 (11)
2012 (19)
2011 (9)
2010 (9)
2009 (13)
2008 (3)
2007 (1)
2003 (1)

Search

Sponsor content

496 result(s) found, displaying 421 to 430

SOUTHERN CROSS PHARMA MINOXIDIL 5% topical application bottle Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
CARVEDILOL GENERICHEALTH carvedilol 3.125 mg tablet blister pack Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
CARVEDILOL GENERICHEALTH carvedilol 6.25 mg tablet blister pack Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
CARVEDILOL GENERICHEALTH carvedilol 12.5 mg tablet blister pack Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
CARVEDILOL GENERICHEALTH carvedilol 25 mg tablet blister pack Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
ATORVASTATIN AN atorvastatin (as calcium) 10 mg film-coated tablets blister pack Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
ATORVASTATIN AN atorvastatin (as calcium) 20 mg film-coated tablets blister pack Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
ATORVASTATIN AN atorvastatin (as calcium) 40 mg film-coated tablets blister pack Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
ATORVASTATIN AN atorvastatin (as calcium) 80 mg film-coated tablets blister pack Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
NEVIRAPINE SCP nevirapine 200 mg tablet blister pack (199199)

30 July 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NEVIRAPINE SCP nevirapine 200 mg tablet blister pack.

Pages

First page
Previous page
…
Page 39
Page 40
Page 41
Page 42
Current page 43
Page 44
Page 45
Page 46
Page 47
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.